We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
951
iShares Core S&P Mid-Cap ETF
IJH
$124B
$432K ﹤0.01%
+7,379
New +$434K
ARWR icon
952
Arrowhead Research
ARWR
$12B
$428K ﹤0.01%
16,465
-825
-5% -$20.3K
FBP icon
953
First Bancorp
FBP
$4.28B
$427K ﹤0.01%
23,361
+2,086
+10% +$36.5K
ASB icon
954
Associated Banc-Corp
ASB
$5.84B
$426K ﹤0.01%
20,119
-1,390
-6% -$29.3K
PCH
955
DELISTED
PotlatchDeltic
PCH
$423K ﹤0.01%
10,742
-651
-6% -$27.6K
FIVN icon
956
FIVE9
FIVN
$2.54B
$421K ﹤0.01%
9,554
+153
+2% +$7.95K
NSIT icon
957
Insight Enterprises
NSIT
$4.57B
$419K ﹤0.01%
2,114
+52
+3% +$10.1K
BLKB icon
958
Blackbaud
BLKB
$2.21B
$419K ﹤0.01%
5,500
-634
-10% -$48.8K
CUZ icon
959
Cousins Properties
CUZ
$4.85B
$418K ﹤0.01%
18,044
-3,315
-16% -$76.3K
NWE icon
960
NorthWestern Energy
NWE
$4.33B
$417K ﹤0.01%
8,327
-511
-6% -$25.8K
IBOC icon
961
International Bancshares
IBOC
$4.41B
$415K ﹤0.01%
7,255
-444
-6% -$25K
FTI icon
962
TechnipFMC
FTI
$29.7B
$409K ﹤0.01%
15,642
-314
-2% -$8.09K
RDN icon
963
Radian Group
RDN
$4.82B
$408K ﹤0.01%
13,121
+321
+3% +$9.91K
SPXC icon
964
SPX Corp
SPXC
$9.95B
$407K ﹤0.01%
2,864
+189
+7% +$24.9K
CNO icon
965
CNO Financial Group
CNO
$5.12B
$406K ﹤0.01%
14,640
-1,215
-8% -$33.2K
MLI icon
966
Mueller Industries
MLI
$13.9B
$406K ﹤0.01%
14,246
+604
+4% +$16.9K
VLY icon
967
Valley National Bancorp
VLY
$7.69B
$405K ﹤0.01%
58,024
-3,681
-6% -$26.9K
GMS
968
DELISTED
GMS Inc
GMS
$404K ﹤0.01%
5,017
-17
-0.3% -$1.57K
COTY icon
969
Coty
COTY
$2.51B
$404K ﹤0.01%
40,302
-4,471
-10% -$47.9K
GTM
970
ZoomInfo Technologies
GTM
$1.22B
$404K ﹤0.01%
31,621
-17,317
-35% -$242K
BYD icon
971
Boyd Gaming
BYD
$5.77B
$403K ﹤0.01%
7,315
-1,033
-12% -$59K
ALKS icon
972
Alkermes
ALKS
$7.95B
$402K ﹤0.01%
16,694
-261
-2% -$6.4K
LIVN icon
973
LivaNova
LIVN
$4.43B
$401K ﹤0.01%
7,314
-433
-6% -$24.7K
KRC icon
974
Kilroy Realty
KRC
$4.21B
$396K ﹤0.01%
12,708
-2,001
-14% -$66.5K
VC icon
975
Visteon
VC
$2.72B
$396K ﹤0.01%
3,712
-254
-6% -$28.1K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.